Press Announcements > FDA approves new DNA-based test to determine blood compatibility

Press Announcements > FDA approves new DNA-based test to determine blood compatibility

FDA approves new DNA-based test to determine blood compatibility

Test is first approved to report genotypes as final results

The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.